Skip to main content

Advertisement

Table 2 Measured data (mean ± standard deviation) and p-values for unpaired t-tests between the two treatment groups

From: Vertebral bone marrow fat fraction changes in postmenopausal women with breast cancer receiving combined aromatase inhibitor and bisphosphonate therapy

 BaselineFollow-up
 AI+BP (n = 14)AI-BP (n = 8)p-valueAI+BP (n = 14)AI-BP (n = 8)p-value
PDFF [%]45.66 ± 9.7245.88 ± 6.950.95648.40 ± 10.6947.03 ± 7.250.750
BMD [g/cm2]1.247 ± 0.2521.186 ± 0.1790.5541.270 ± 0.2701.177 ± 0.1710.390